RTPM and Insurance Claims: What Insurers Need to Know

Practical application of real-time prescription monitoring for claims management

3 April 2026

Introduction

Real-time prescription monitoring (RTPM) systems provide insurers with unprecedented visibility into controlled medication prescribing patterns. However, having access to RTPM data requires understanding how to interpret patterns, respond appropriately, and integrate this intelligence into your claims management strategy. This guide explains what insurers need to know to use RTPM effectively for claims management and claimant protection.

How Insurance Teams Access RTPM Data

Insurance teams access RTPM information through several channels:

Direct Access

Some large insurers have direct access to RTPM systems (SafeScript, QScript) through their claims management software platforms. Your claims team can query your claimant's RTPM history directly.

Clinical Pharmacist Review

Clinical pharmacy teams conducting medication reviews incorporate RTPM data into their assessment. They query RTPM systems and interpret data through clinical context, providing you with analysis rather than raw data.

Prescriber or Pharmacist Alert

When RTPM systems detect concerning patterns, prescribers or pharmacies may notify you directly. For example, a pharmacist might alert your team that your claimant has filled multiple opioid prescriptions from different prescribers.

Indirect Notification

Regulatory or law enforcement agencies may notify you of RTPM-identified concerns if they investigate suspected fraud related to your claimant's insurance claim.

What RTPM Data Tells You About Your Claims

RTPM data reveals patterns suggesting medication abuse, fraud, or inappropriate prescribing. Understanding what these patterns mean helps you respond appropriately:

Multiple Prescribers for Same Medication

When RTPM shows your claimant obtaining the same controlled medication (e.g., oxycodone) from multiple prescribers within days, this suggests either doctor shopping (fraud) or lack of prescriber coordination (quality concern). Response: clinical pharmacist review, prescriber communication, or fraud investigation depending on context.

Rapid Dose Escalation

RTPM showing monthly increases in controlled medication doses may suggest tolerance development, medication abuse, or inadequate pain management. Response: clinical review to assess whether escalation is medically justified or whether your claimant should transition to alternative pain management strategies.

Prescriptions Before Previous Supply Exhausted

RTPM showing your claimant obtaining a new opioid prescription before the previous month's supply would be consumed suggests medication diversion (your claimant is sharing or selling medications) or non-compliance. Response: clinical review, prescriber communication, or investigation depending on frequency and context.

Pharmacy Jumping

RTPM showing your claimant filling prescriptions from the same prescriber at multiple different pharmacies within short timeframes suggests an attempt to avoid dispensary detection of medication patterns. Response: clinical review and prescriber communication to understand whether there's a legitimate reason or whether medication abuse is occurring.

Integrating RTPM Data into Your Claims Strategy

Effective use of RTPM requires integration into your broader claims management approach:

Risk Stratification

Use RTPM data to identify claimants at high risk for medication-related complications or fraud. High-risk claimants warrant priority for clinical medication review and more frequent monitoring.

Early Intervention

Rather than waiting for medication-related complications to emerge, use RTPM alerts to intervene early through clinical review, prescriber communication, or medication adjustment. Early intervention prevents complications and reduces claims costs.

Prescriber Engagement

When RTPM data suggests concerning patterns, use this data to engage your claimant's prescriber in constructive discussion. Data-driven conversations about medication patterns are more effective than complaints and often result in medication adjustments that improve outcomes.

Clinical Pharmacy Integration

Embed RTPM data into your clinical pharmacy review processes. Clinical pharmacists can interpret RTPM patterns through medical context and provide specific recommendations for response.

RTPM Limitations and Response Strategies

Understanding RTPM limitations helps you avoid overreacting to data:

• Limited medication scope: RTPM tracks Schedule 8 and certain controlled medications but not all substances of concern. Claimants may abuse non-controlled medications or other substances not visible through RTPM.
• No clinical context: RTPM shows prescribing patterns but not medical justification. Always pair RTPM data with clinical review to interpret patterns appropriately.
• False positives: Some concerning patterns reflect legitimate medical practice. For example, a pain specialist might prescribe multiple opioid formulations (different delivery systems) for the same claimant, creating a pattern that could appear suspicious without clinical context.
• Lag time: While RTPM is "real-time," there can be minor delays between dispensing and data visibility. Don't assume gaps in data mean your claimant hasn't obtained medications.

Case Examples: Using RTPM in Claims Management

Scenario 1: Doctor Shopping Detection RTPM shows your claimant obtained oxycodone from prescriber A on Day 1, prescriber B on Day 3, and prescriber C on Day 5. This pattern suggests doctor shopping. Response: alert your claimant's primary care doctor, conduct clinical review, and potentially refer for substance abuse assessment if pattern continues.

Scenario 2: Dose Escalation RTPM shows your claimant's oxycodone dose increased from 30mg daily to 100mg daily over 6 months. Response: clinical review to determine if escalation reflects appropriate pain management or tolerance suggesting medication abuse. If abuse suspected, discuss medication management adjustment with prescriber.

Scenario 3: Legitimate Polypharmacy RTPM shows your claimant obtaining multiple opioid prescriptions (extended-release formulation, short-acting formulation, and transdermal patch). Response: review medical records to confirm this represents legitimate multimodal pain management, not medication abuse. If appropriate, monitor but don't escalate unnecessarily.

Legal and Ethical Considerations

Using RTPM data requires attention to privacy and ethical considerations:

• RTPM data is sensitive health information; maintain confidentiality in accordance with privacy legislation.
• Respond to RTPM alerts through appropriate channels (clinical review, prescriber communication) rather than confrontational accusations of fraud without supporting evidence.
• Distinguish between patterns suggesting legitimate medical complexity and patterns clearly indicating abuse or fraud.
• Partner with clinical experts when interpreting RTPM data to ensure appropriate response.

Conclusion

RTPM provides insurers with powerful intelligence for identifying medication abuse, fraud, and inappropriate prescribing. Effective use requires understanding what RTPM detects, what patterns mean, and how to respond appropriately through clinical review, prescriber engagement, and medication management adjustment. Combined with clinical pharmacist expertise, RTPM data becomes actionable intelligence supporting both claimant safety and insurance risk management.